Display options
Share it on

Cancer Radiother. 2021 Dec;25(8):830-836. doi: 10.1016/j.canrad.2021.08.016. Epub 2021 Oct 27.

[Stereotactic body radiation therapy for spine bone oligometastatic disease].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

[Article in French]
S Thureau, M Rogé, V Marchesi, A Hadj Henni, J C Faivre

Affiliations

  1. Département de radiothérapie et de physique médicale, centre Henri-Becquerel-CLCC-Unicancer, Quantif-Litis EA 4108, rue d'Amiens, 76038 Rouen, France. Electronic address: [email protected].
  2. Département de radiothérapie et de physique médicale, centre Henri-Becquerel-CLCC-Unicancer, Quantif-Litis EA 4108, rue d'Amiens, 76038 Rouen, France.
  3. Lorraine Institute of Cancerology-Alexis-Vautrin Comprehensive Cancer Center, Academic Radiation Oncology & Brachytherapy Department, 6, avenue de Bourgogne, Vandoeuvre Lès Nancy 4519, France.

PMID: 34716092 DOI: 10.1016/j.canrad.2021.08.016

Abstract

Stereotactic radiotherapy is an ever more common technique, regardless of the location treated. However, spinal stereotactic radiotherapy requires a particular technicality in order to ensure its proper realization. There is now a large literature defining the type of imaging to be used, the dose to be delivered and the delineation of target volumes. This technique can achieve a significant local control and an interesting analgesic efficiency. However, its place in relation to conventional radiotherapy remains limited because it requires MRI imaging and a significantly longer patient management during the treatment fraction. In this context, it is currently mainly restricted to oligometastatic patients or for re-irradiations.

Copyright © 2021 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Keywords: Bone metastases; Métastases osseuses; Rachis; Spine; Stereotactic radiotherapy; Stéréotaxie

Publication Types